Skip to main content

FDA Detention Sampling & Testing Services

Step by Step

How the FDA Detention Sampling Process Works

From the moment you send your FDA Notice of Action to the day organized laboratory reports land in your hands, a detention sampling case moves through five coordinated stages. Here is what happens at each one — who's involved, what you provide, and where time is won or lost.

  • Five Coordinated Stages
  • Clear Timing Expectations
  • Every Party's Role Defined
  • No Hidden Steps
Coordinator reviewing shipment documents and a sampling plan for an FDA-detained import
Independent private company. Not affiliated with the U.S. Food and Drug Administration.

The Short Version

What Does the Sampling Process Look Like?

The FDA detention sampling process moves through five stages: you submit the FDA notice and shipment details; the case information is reviewed to define the sampling and testing plan; shipment access and collection are coordinated at the holding facility; documented samples travel to an independent laboratory; and you receive organized laboratory reports and custody records for use by your authorized parties. Each stage's specifics depend on your product, facility, and detention reason.

The detailed walkthrough of each stage follows below.

The Full Walkthrough

The Five Stages of a Detention Sampling Case

Each stage below shows what happens, what you provide, what gets coordinated, and — because honesty helps you plan — what most commonly slows that stage down.

  1. Submit the FDA Notice and Case Information

    Everything starts with your FDA Notice of Action. It identifies the entry, the detention reason, and the response window — the three facts that shape the entire plan. Alongside it, the shipment's basic details let the practical work be assessed accurately.

    You provide

    • FDA Notice of Action and entry number
    • Product name, category, and labels
    • Lot or batch numbers and quantities
    • Shipment location and warehouse contact
    • Import alert number, if applicable
    • Broker, consultant, or attorney contacts

    What happens next

    • Documents are reviewed at intake
    • Urgent matters get priority review
    • Missing items are identified early
    • Initial feasibility is assessed

    Most common delay: an incomplete first submission — especially a missing warehouse contact or shipment location. Send everything you have in the first message, even if imperfect.

  2. Review the Case and Define the Plan

    The available information is reviewed to identify the likely sampling, handling, laboratory, and logistical needs — and, critically, the laboratory's sample requirements are confirmed before anyone touches the shipment. The proposed coordination scope comes back to you for review before work begins.

    Defined at this stage

    • The analysis matched to the detention reason
    • Candidate independent laboratories and methods
    • Accreditation needs (LAAF where applicable)
    • Sample quantity, packaging, and temperature needs
    • Scope, limitations, and third-party charges

    Who weighs in

    • You and your customs broker
    • Your regulatory consultant or attorney, if engaged
    • The candidate laboratory on requirements

    Most common delay: unclear testing direction. If your notice's charge is ambiguous, a consultant or attorney may need to confirm strategy before the plan can lock.

  3. Coordinate Shipment Access and Sampling

    The facility holding your cargo — warehouse, cold storage, bonded facility, or container freight station — is contacted, authorization is confirmed, and a qualified sampling resource is coordinated for collection. Samples are drawn per the plan, identified, sealed with numbered tamper-evident seals, and photographed where permitted.

    Coordinated here

    • Facility authorization and scheduling
    • Sampler availability and instructions
    • Representative collection across the lot
    • Sealing, labeling, and condition records
    • Photographs, where permitted

    Subject to

    • Facility rules and authorization
    • Shipment availability and safety requirements
    • Sampler availability at the location

    Most common delay: facility authorization. Warehouses move on their own paperwork and schedules — early, direct contact with the right person at the facility is the fix. See how collection is documented.

  4. Transfer Samples to the Laboratory

    Sealed samples are packaged to the laboratory's specifications — leak-resistant, temperature-controlled where the product requires it — and moved by coordinated courier with tracking. Every transfer is signed and time-stamped; the laboratory documents arrival condition, seal integrity, and temperature on receipt, closing the custody chain.

    Coordinated here

    • Packaging to laboratory specification
    • Refrigerated or frozen transport when required
    • Courier pickup, tracking, and timing
    • Laboratory receiving hours and cut-offs
    • Receipt confirmation and condition record

    Then the analysis runs

    • The laboratory performs the agreed methods
    • Method-mandated incubation periods apply
    • Turnaround follows the laboratory's estimate

    Most common delay: missing a receiving cut-off — a Friday-afternoon pickup that sits until Monday. Receiving hours are confirmed up front so cold-chain samples never wait on a dock.

  5. Receive Results and the Organized Case File

    The laboratory issues its report, tied by sample IDs to your custody records. Reports, chain-of-custody documentation, photographs, and shipment records are organized into a coherent case file and delivered to you and the parties you authorize — your broker, consultant, or attorney handling the response.

    You receive

    • The laboratory report(s)
    • Complete chain-of-custody records
    • Collection photographs, where taken
    • An organized, retrievable case file

    What happens with it

    • Your authorized parties decide how results are used
    • Any FDA submission is their decision, not automatic
    • FDA makes the final admissibility decision

    Worth knowing: if a result is unfavorable or insufficient, your options — further analysis, other responses — are decisions for you and your advisors. Coordination doesn't control outcomes.

The Cast

Who Does What in a Detention Sampling Case

A typical case involves up to eight parties. Knowing who owns which decision prevents the most common misunderstanding — expecting one party to control something another party decides.

You

Importer

Owns the entry and the response. Authorizes activity, provides documents, and makes the decisions with professional advice.

Your team

Customs Broker

Manages the entry with CBP and FDA systems, and typically helps authorize activity related to the entry.

Your team

Consultant / Attorney

Sets regulatory strategy, determines what evidence the response needs, and handles any submission to FDA.

Facility

Warehouse

Physically holds the cargo and controls access. Authorizes and schedules sampling under its own procedures.

Coordinated

Sampler

Performs collection per the plan — identified in the custody record, coordinated for the location and product.

Coordinated

Courier

Moves sealed samples to the laboratory with tracking and, where required, temperature control.

Independent

Laboratory

Performs the analysis with its own validated methods and issues its own report. Independent by design.

Us

FDA Detention Sampling

Coordinates all of the above — intake, planning, access, custody, logistics, and the organized case file.

And FDA? FDA reviews the response on its own terms and makes the final admissibility decision. No private party — including us — controls or represents FDA.

Realistic Timing

How Long Does the Whole Process Take?

There's no honest universal number — but there is an honest structure. The total timeline is the sum of three clocks, and only some of them can be compressed:

Compressible

The Coordination Clock

Intake, planning, authorization, scheduling, packaging, courier. This is where organized coordination saves the most time — complete submissions and early facility contact can cut days.

Partly compressible

The Third-Party Clock

Warehouse schedules, sampler availability, courier transit, laboratory queues. Influenced by good coordination and sometimes by rush fees — but ultimately controlled by those parties.

Fixed

The Method Clock

Method-mandated processing and incubation periods. Certain microbiological analyses take the time they take, regardless of urgency or budget.

Once your case is defined, you get a realistic case-specific picture: the laboratory's turnaround estimate plus the coordination steps ahead of it. Note the response deadline on your FDA notice at intake — it shapes the plan from day one.

Common Questions

Questions About the Sampling Process

What should I do first when I receive an FDA Notice of Action?

Read it carefully and note three things: the detention reason, the entry number, and the response deadline. Then gather your entry documents and confirm where the shipment is physically being held.

If laboratory evidence may be part of your response, start the sampling conversation immediately — the coordination clock is the one you control most. You can submit your documents for review the same day you receive the notice.

Can steps run in parallel to save time?

Yes — good coordination overlaps them. Laboratory matching and facility authorization run simultaneously; courier logistics are arranged while sampling is scheduled; the laboratory is expecting the sample before it ships.

What can't overlap is anything that depends on the plan being defined — collection can't responsibly begin before the laboratory's sample requirements are confirmed.

Do I need to be present when samples are collected?

Generally no. Collection is performed by the coordinated sampling resource at the facility, documented in the custody record and, where permitted, in photographs. Your role is authorization and information, not attendance.

If you or your representative want to be present and the facility permits it, that can usually be accommodated in scheduling.

What if my shipment moves to a different facility mid-process?

Tell us immediately — the plan follows the cargo. A facility change means new authorization, possibly a different sampler, and updated logistics, but the laboratory plan and documentation standards stay the same.

Movements of detained cargo are subject to the applicable procedures, which your broker manages; coordination adapts around them.

Who receives the laboratory results?

You, and the parties you authorize — typically your broker, regulatory consultant, or attorney. The complete case file includes the report, custody records, and photographs where taken.

Nothing is submitted to FDA automatically; how and whether results are used in the response is your team's decision.

What does the process cost?

Costs come in two layers: coordination services, and third-party charges billed by the parties that perform the work — sampler, warehouse, laboratory, and courier fees, plus temperature-controlled shipping or rush charges where applicable.

Whenever possible, the full picture — scope plus applicable third-party charges — is reviewed with you before work begins, so nothing is discovered later.

Can the process guarantee my shipment is released?

No — and that answer won't change no matter who you ask, if they're being honest. The process produces documented, traceable laboratory evidence; FDA evaluates the response and makes the final admissibility decision.

What disciplined process work does is remove the avoidable ways evidence fails: unrepresentative samples, custody gaps, wrong methods, and missed logistics.

Review all FDA detention sampling questions

Stage One Starts Here

Start the Process With Your FDA Notice

Send your FDA Notice of Action, entry information, product details, shipment location, and warehouse contact. Intake review begins immediately, and you'll know what's feasible for your shipment before any work starts.

Urgent detention matters receive priority intake review.

FDA Detention Sampling is an independent private company. We are not affiliated with, endorsed by, or part of the U.S. Food and Drug Administration. The process described on this page is general; each case follows its own path based on the product, facility, detention reason, and case-specific requirements. Sampling, laboratory testing, documentation, and coordination services do not guarantee FDA release, admissibility, acceptance of laboratory results, or any specific regulatory outcome. FDA makes the final admissibility decision.